Test Directory
| Test Code | |||
| INTR2 | |||
| Test Name | |||
| IL-2 Receptor Alpha | |||
| CPT Codes | |||
| 83520 | |||
| Expected Turnaround Time | |||
| 3 - 6 days | |||
| Clinical Utility | |||
|
This test is used for the measurement of Interleukin-2 Soluble Receptor α (sIL-2Rα) levels in serum. |
|||
| Specimen and Container Info | |||
|
Specimen Type: Serum
Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Plain Desired Specimen Volume: 0.5 mL |
|||
| Collection Instructions | |||
|
|||
| Processing and Submission Instructions | |||
|
|||
| Transport Instructions | |||
|
Transport to the laboratory frozen. |
|||
| Stability Requirements | |||
|
|||
| Causes for Rejection | |||
|
|||
| Methodology | |||
| Immunochemiluminometric Assay (Icma) | |||
| Reference Intervals | |||
|
See patient report. |
|||
| Limitations | |||
|
sIL-2Rα level is only one out of eight criteria of which five have to be met to make a diagnosis. The combination of these clinical and laboratory criteria should warrant sufficient specificity. In order to reach a high specificity close to 100%, levels >10,000 U/mL are required. The clinical presentation of HLH can have considerable overlap with other inflammatory conditions. A normal or only modestly elevated sIL-2Rα, despite extremely elevated ferritin, suggests disseminated infection in the context of primary immunodeficiencies, especially in an infant. Although high levels of sIL-2Rα may be suggestive of sarcoidosis, there is substantial overlap in patients with other interstitial lung diseases. |
|||
| Alternate Names | |||
|
|||
| Reference Lab | |||
| Labcorp Of America Holdings | |||
| Testing Schedule | |||
| Routine, 2 times per week | |||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.